Literature DB >> 16499980

Sm22.6 antigen is an inhibitor to human thrombin.

Ya-Ling Lin1, Shiping He.   

Abstract

The physiological role of Schistosomiasis mansoni 22.6 antigen (sm22.6 Ag) and its pathogenic effect on the human host has never been reported. Recombinant sm22.6 Ag is a homogenous polymer under non-denaturing/non-reducing conditions, and an inhibitor to human thrombin. Kinetic and Western blot assays show that the recombinant protein interacts with human thrombin and inhibits proteolytic activity of the protease. Tests of whole blood revealed that coagulation time was significantly delayed (3-5 times longer) in the presence of the recombinant protein at a concentration similar to thrombin in normal blood samples. Kinetic studies revealed that the delayed coagulation time was due to the inhibition of alpha-thrombin proteolytic activity by the parasite protein in an irreversible pattern, and a reversible inhibition to gamma-thrombin. Also, Western blot analysis under non-denaturing/non-reducing conditions showed that sm22.6 Ag binds to both alpha- and gamma-thrombin. Our results strongly suggest that sm22.6 antigen plays a role in down-regulation of coagulation in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16499980     DOI: 10.1016/j.molbiopara.2006.01.012

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  14 in total

1.  The impact of schistosomes and schistosomiasis on murine blood coagulation and fibrinolysis as determined by thromboelastography (TEG).

Authors:  Akram A Da'dara; Armelle M de Laforcade; Patrick J Skelly
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

2.  Infection of Schistosomiasis japanicum is likely to enhance proliferation and migration of human breast cancer cells: mechanism of action of differential expression of MMP2 and MMP9.

Authors:  Ya-Ling Lin; Rakesh Ramanujum; Shiping He
Journal:  Asian Pac J Trop Biomed       Date:  2011-01

Review 3.  Interference with the host haemostatic system by schistosomes.

Authors:  Mirjam M Mebius; Perry J J van Genderen; Rolf T Urbanus; Aloysius G M Tielens; Philip G de Groot; Jaap J van Hellemond
Journal:  PLoS Pathog       Date:  2013-12-26       Impact factor: 6.823

4.  Sm29, but not Sm22.6 retains its ability to induce a protective immune response in mice previously exposed to a Schistosoma mansoni infection.

Authors:  Clarice Carvalho Alves; Neusa Araujo; Viviane Cristina Fernandes dos Santos; Flávia Bubula Couto; Natan R G Assis; Suellen B Morais; Sérgio Costa Oliveira; Cristina Toscano Fonseca
Journal:  PLoS Negl Trop Dis       Date:  2015-02-27

5.  Comparative biochemical analysis of three members of the Schistosoma mansoni TAL family: Differences in ion and drug binding properties.

Authors:  Charlotte M Thomas; Colin M Fitzsimmons; David W Dunne; David J Timson
Journal:  Biochimie       Date:  2014-11-05       Impact factor: 4.079

Review 6.  Schistosome-Derived Molecules as Modulating Actors of the Immune System and Promising Candidates to Treat Autoimmune and Inflammatory Diseases.

Authors:  Luis Janssen; Gisele Lorranna Silva Santos; Herick Sampaio Muller; Anderson Rodrigues Araújo Vieira; Tatiana Amabile de Campos; Vicente de Paulo Martins
Journal:  J Immunol Res       Date:  2016-08-21       Impact factor: 4.818

7.  Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.

Authors:  Marwa H El-Faham; Maha M Eissa; Joseph E Igetei; Eglal I Amer; Susan Liddell; Mervat Z El-Azzouni; Michael J Doenhoff
Journal:  PLoS Negl Trop Dis       Date:  2017-08-25

8.  Transcriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytes.

Authors:  Geoffrey N Gobert; Mai H Tran; Luke Moertel; Jason Mulvenna; Malcolm K Jones; Donald P McManus; Alex Loukas
Journal:  PLoS Negl Trop Dis       Date:  2010-02-09

Review 9.  Understanding the Pathophysiology of Exosomes in Schistosomiasis: A New Direction for Disease Control and Prevention.

Authors:  Yue Yuan; Jianping Zhao; Min Chen; Huifang Liang; Xin Long; Bixiang Zhang; Xiaoping Chen; Qian Chen
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

10.  Vesicle-based secretion in schistosomes: Analysis of protein and microRNA (miRNA) content of exosome-like vesicles derived from Schistosoma mansoni.

Authors:  Vitalie Samoil; Maude Dagenais; Vinupriya Ganapathy; Jerry Aldridge; Anastasia Glebov; Armando Jardim; Paula Ribeiro
Journal:  Sci Rep       Date:  2018-02-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.